Back to top
more

Franklin Strategic Series Biotech Dsc Advsr: (MF: FTDZX)

(NASDAQ Mutual Funds) As of Jul 10, 2020 08:00 PM ET

 Add to portfolio

$180.43 USD

-1.82 (-1.00%)

Zacks MF Rank NA

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of May 31, 2020

Total Return %* Percentile Rank Objective
YTD 9.66 9
3 months 13.95 28
6 months 13.39 7
1 Year 34.07 8
3 Year 12.18 64
5 Year 1.93 89
10 Year NA NA

* Annual for three years and beyond.

Zacks Premium Research for FTDZX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 40.69
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 5/31/2020 171.44
%Turnover 5/31/2020 28.62

Risk

3 Year 5 Year 10 Year
Beta 1.04 1.21 NA
Alpha 2.95 -6.96
R Squared 0.51 0.48 NA
Std. Dev. 24.56 25.87 NA
Sharpe 0.55 0.17 NA

Sector / Country Weightings

As of 5/31/2020 % of Portfolio
Health 65.38
Other 22.13
Services 7.99
Technology 4.50

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2020)
% of Portfolio Value (Mil$)
VERTEX PHARMACEUTICALS IN 7.08 80.35
AMGEN INC 6.69 75.94
GILEAD SCIENCES INC 5.80 65.85
ILLUMINA INC 4.50 51.05
NA 4.48 50.88
NA 4.47 50.79
GW PHARMACEUTICALS PLC 3.91 44.41
DECIPHERA PHARMACEUTICALS 3.83 43.52
REGENERON PHARMACEUTICALS 3.81 43.26

Stock Holding % of Net Assets

As Of 1/31/2020
Total Issues 78
Avg. P/E 35.85
Avg. P/Book 4.30
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 28,062

Allocation

% of Portfolio
Large Growth 66.72
Large Value 0.00
Small Growth 19.90
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00